<DOC>
	<DOCNO>NCT01895413</DOCNO>
	<brief_summary>This non-randomized study aim determine safety efficacy intra-articular injection autologous bone marrow-derived mesenchymal stem cell patient knee articular cartilage defect .</brief_summary>
	<brief_title>Autologous Bone Marrow Mesenchymal Stem Cells Transplantation Articular Cartilage Defects Repair</brief_title>
	<detailed_description>Osteoarthritis prevalent joint disease , create articular cartilage defect frequent cause joint pain , functional loss , disability . Osteoarthritis often become chronic , conventional treatment seek ameliorate pain improve mobility . However , treatment rarely modify course disease.Recent study cell-based show encouraging result animal study human case report . We design study ass safety efficacy osteoarthritis treatment intra-articular injection autologous bone marrow-derived mesenchymal stem cell .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Diagnosed mild moderate osteoarthritis ( visual analogue scale ) History joint swelling , pain , stiffness , alter gait loss motion due degenerative cartilage Any past history neoplasia primary hematological disease Autoimmune disease medical history Systemic bone cartilage disorder Acute chronic communicable disease include Hepatitis B , Hepatitis C HIV Comorbidity physician deem contraindication stem cell transplantation bone marrow biopsy Evidence infection fracture around joint Contraindication bone marrow aspiration Deviation axial axis ( varus valgus ) great 12 degree .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Cartilage injury</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Mesenchymal stem cell</keyword>
</DOC>